Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 13, Number 3—March 2007

Letter

Drug-resistant Nontyphoidal Salmonella Bacteremia, Thailand1

Wanla Kulwichit*Comments to Author , Tanittha Chatsuwan*, Chudaachhara Unhasuta*, Chaiwat Pulsrikarn, Aroon Bangtrakulnonth, and Anan Chongthaleong*
Author affiliations: *Chulalongkorn University, Bangkok, Thailand; and †World Health Organization National Salmonella and Shigella Center, Bangkok, Thailand;

Main Article

Figure

Percentage of nontyphoidal Salmonella isolates resistant to nalidixic acid (NA) and ceftriaxone (CTRX), Thailand. KCMH, King Chulalongkorn Memorial Hospital; WHO-Salm, World Health Organization Salmonella and Shigella Center. Cho, Choleraesuis; non-Cho, non-Choleraesuis. The analysis included 10 Cho isolates from KCMH, 44 Cho isolates from WHO-Salm, 27 non-Cho isolates from KCMH, and 41 non-Cho isolates from WHO-Salm. Two Cho isolates from WHO-SAlm with intermediate MICs for ceftriaxone are also

Figure. Percentage of nontyphoidal Salmonella isolates resistant to nalidixic acid (NA) and ceftriaxone (CTRX), Thailand. KCMH, King Chulalongkorn Memorial Hospital; WHO-Salm, World Health Organization Salmonella and Shigella Center. Cho, Choleraesuis; non-Cho, non-Choleraesuis. The analysis included 10 Cho isolates from KCMH, 44 Cho isolates from WHO-Salm, 27 non-Cho isolates from KCMH, and 41 non-Cho isolates from WHO-Salm. Two Cho isolates from WHO-SAlm with intermediate MICs for ceftriaxone are also included.

Main Article

1Presented at the 16th European Congress of Clinical Microbiology and Infectious Diseases, April 1–4, 2006, Nice, France.

TOP